Company / Capital Returned to Shareholders per Share
Quest Diagnostics Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$7.11
FY2025
5-year range
$4.08 / $19.59
FY2021-FY2025
Trend
+74.0%
vs FY2024
Sector context
#19 of 108
Health Care
What the data says
Quest Diagnostics's capital returned to shareholders per share of $7.11 is higher than 82% of companies in the Health Care sector (FY2025). Capital Returned to Shareholders per Share has fluctuated over the past 10 years, ranging from $2.20 in FY2016 to $19.59 in FY2023.
Based on SEC 10-K filings.
7.11 in FY2025 with a 5-year CAGR of +9.7%. Top quartile in the Health Care sector.
Declined from $19.59 to $7.11 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- +15.8%
- 5-Year CAGR
- +9.7%
- 10-Year CAGR
- -
Sector benchmark
+43.8% above sector average
Key checks
Key Insights
- In FY2025, capital returned to shareholders per share increased 74.0% year-over-year.
- Ranks #19 out of 108 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2023.
- Lowest capital returned to shareholders per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.11 | +74.0% |
| FY2024 | $4.08 | -79.2% |
| FY2023 | $19.59 | +328.4% |
| FY2022 | $4.57 | -2.7% |
| FY2021 | $4.70 | +5.0% |
| FY2020 | $4.47 | -12.0% |
| FY2019 | $5.09 | -11.2% |
| FY2018 | $5.73 | +90.4% |
| FY2017 | $3.01 | +36.7% |
| FY2016 | $2.20 | -72.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026